Atlas Trials

Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment

Clinical trial NCT00226382 · COMPLETED

Trial details

NCT number
NCT00226382
Sponsor
Chinese University of Hong Kong
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis B
Start date
2005-01-01
Primary completion
2008-04-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.